Medical Information
|
Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
    Medical Information
    |
    Non-US Health Care Professionals
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
    Medical Information
    |
    Non-US Health Care Professionals
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
    Medical Information
    |
    Non-US Health Care Professionals
Rare Renal Disorders
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg logo
  • Understanding PH1
  • About Rivfloza®
  • Efficacy and Safety
  • Dosing and Administration
  • Start Your Patients
  • Resources
Prescribing Information | Important Safety Information

Explore Therapeutic Areas

Diabetes Icon
Diabetes
Our broad treatment portfolio supports individualized patient care.
Obesity Icon
Obesity
Our treatments are part of a comprehensive approach to weight-loss management.
Growth-Related Disorders Icon
Growth-Related Disorders
Our products help children with a range of growth-related disorders and adults with growth hormone deficiency.
Rare Bleeding Disorders Icon
Rare Bleeding Disorders
Our commitment to patients with hemophilia and rare bleeding disorders is reflected in our broad therapy portfolio.
Rare Renal Disorders Icon
Rare Renal Disorders
Our treatment helps patients with the rare genetic disorder primary hyperoxaluria type 1 (PH1).
Medical Information
|
Non-US Health Care Professionals
  • Rare Renal Disorders Home
  • Contact Your Representative
Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals

Explore the Hub

Products
Samples
Patient Savings
Contact

Explore Therapeutic Areas

Diabetes
Diabetes
Obesity
Obesity
Growth-Related Disorders
Growth-Related Disorders
Rare Bleeding Disorders
Rare Bleeding Disorders
Rare Renal Disorders
Rare Renal Disorders
Claim your personalized professional hub
What can novoMEDLINK™ do for you? With your account you can discover professional news, order samples, get supply updates, browse patient support materials, and much more.
Personalize your novoMEDLINK™ experience
Ready to further optimize your content recommendations and resource suggestions? Head to your account page to edit your settings.
Account Settings
Sign Out
Sign In | Create Account
Update your account
  • Products
    Samples
    Patient Savings
    Contact
    Diabetes
    Diabetes
    Obesity
    Obesity
    Growth-Related Disorders
    Growth-Related Disorders
    Rare Bleeding Disorders
    Rare Bleeding Disorders
    Rare Renal Disorders
    Rare Renal Disorders
Claim your personalized
professional hub
Personalize your novoMEDLINK™ experience
Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals
  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
Medical Information
|
Non-US Health Care Professionals

Explore Current Therapy Area

Rare Renal Disorders Home
Product
PH1 Product Information
Product Resources Library
Disease Education
What Is PH1?
Identifying & Diagnosing
Product Education
Patient Education Materials
Additional Resources
Professional & Patient Organizations
Diabetes
Diabetes
Obesity
Obesity
Growth-Related Disorders
Growth-Related Disorders
Rare Bleeding Disorders
Rare Bleeding Disorders
Rare Renal Disorders
Rare Renal Disorders
Medical Information
|
Non-US Health Care Professionals
Claim your personalized professional hub
What can novoMEDLINK™ do for you? With your account you can discover professional news, order samples, get supply updates, browse patient support materials, and much more.
Personalize your novoMEDLINK™ experience
Ready to further optimize your content recommendations and resource suggestions? Head to your account page to edit your settings.
Account Settings
Sign Out
Sign In | Create Account
Update your account

Explore Current Therapy Area

  • Rare Renal Disorders Home
  •  Icon
    Product
    PH1 Product Information
    Product Resources Library
  • Contact Your Representative
  •  Icon
    Disease Education
    What Is PH1?
    Identifying & Diagnosing
  •  Icon
    Product Education
    Patient Education Materials
     Icon
    Additional Resources
    Professional & Patient Organizations
  • Diabetes
    Diabetes
    Obesity
    Obesity
    Growth-Related Disorders
    Growth-Related Disorders
    Rare Bleeding Disorders
    Rare Bleeding Disorders
    Rare Renal Disorders
    Rare Renal Disorders

Claim your personalized
professional hub

Personalize your novoMEDLINK™ experience

Account Settings
Sign Out
Sign In | Create Account
Update your account
Medical Information
|
Non-US Health Care Professionals
  • Understanding PH1
  • About Rivfloza®
  • Efficacy and Safety
  • Dosing and Administration
  • Start Your Patients
  • Resources
Prescribing Information | Important Safety Information
Medical Information
|
Non-US Health Care Professionals
Prescribing Information  |  Important Safety Information

For adults and children aged 2 years and older with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

NovoCare® provides support every step of the way

NovoCare® is designed to help patients start and stay on therapy as prescribed. 

NovoCare® provides support every step of the way

NovoCare® is designed to help patients start and stay on therapy as prescribed. 

Start with the Patient Enrollment Form (PEF)

Use this form to enroll your patients in the NovoCare® program and verify their insurance benefits.

You can also use the PEF to request any of the following resources: starter kit, JumpStart™, NovoCare® Savings Offer, and injection training. After submitting, a Patient Liaison will reach out to your patient to complete their portion of the enrollment and welcome them to the program.

View electronic form

Download PEF

NovoCare® provides support for you and your patients

Once a PEF is submitted, your patient is assigned a case manager who ensures proper paperwork and documentation are submitted. They are the go-to experts to help understand the range of services offered including:

Shield with checkmark icon

Benefit verification

Health care professionals (HCPs) can request a benefit verification by completing the PEF and sending it to NovoCare®.

Phone conversation icon

Live support for patients

Once a PEF is submitted to NovoCare®, every patient is assigned a dedicated Patient Liaison.a They will be the patient’s primary contact for support throughout their treatment journey.

Form icon

Prior authorization (PA) assistance

This assistance helps you and your patients navigate the insurance process by obtaining payer requirements for the PA process.

Person with headset icon

Appeals assistance

Should a patient’s insurance deny coverage, NovoCare® can assist by providing support and information about the appeals process.

Vial and syringe

JumpStart™

Provides limited free product to eligible patients who are experiencing a gap or delay in getting insurance coverage.

Eligibility and restrictions apply. Call NovoCare® at 1-844-906-5099 to see if you are eligible.

Co-pay card icon

Co-pay assistance

A savings offer provides financial assistance to eligible patients.

Syringe

Injection training

Professionalsa will provide live, in-person, or virtual injection training.

Hands holding icon

Patient Assistance Program (PAP)

This program will support eligible patients prescribed Novo Nordisk medications, free of charge.

aPatient Liaisons and injection trainers have a background in nursing. They are working on behalf of Novo Nordisk, the pharmaceutical company. Their role is to provide injection training and support. They are not acting as health care providers. Patients and caregivers must speak with their health care provider for any questions regarding medical care or advice.

NovoCare® logo

Need assistance?

Call NovoCare® at 1-844-906-5099 8:00 AM-8:00 PM ET, Monday-Friday.

Learn more about NovoCare®
Rivfloza® savings card

Help patients save

If your patients have commercial insurance, such as insurance they receive through an employer, they may be eligible to pay as little as $0 per fill of Rivfloza® (with annual maximum cap of $15,000).

Sign up for savings
Eligibility and other restrictions apply.
Form icon

Resources dedicated to you and your patients

View resources

Person with headset icon

Have questions about Rivfloza®? Reach out to our team of representatives

Connect with a representative

Show More Show Less

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Show More Show Less
Show More Show Less

Indication and Usage

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Indication and Usage

Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.

Important Safety Information for Rivfloza®

Adverse Reactions

Most common adverse reactions (reported in ≥20% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.

Please click here for Rivfloza® Prescribing Information.

For Health Care Professionals
  • Rare Renal Disorders Home
  • Product Information
    Product
    • PH1 Product Information
      Product Resources Library
  • Contact Your Representative
  • Professional Education
    Disease Education
    • What Is PH1?
      Identifying & Diagnosing
  • Patient Support
    Product Education
    • Patient Education Materials
    Additional Resources
    • Professional & Patient Organizations

PHYOX™ is a trademark and Rivfloza® is a registered trademark of Novo Nordisk Health Care AG.
novoMEDLINK™ is a trademark and NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Terms of Use | Privacy Notice | Consumer Health Privacy Notice | Cookie Notice | Privacy Request | Contact Us |
novonordisk-us.com    
© 2025 Novo Nordisk All rights reserved. US25RVZA00017 May 2025

What can we help you do today?

Quick links

 

 

Medical Information     |     Non-US Health Care Professionals